FREE PREMIUM SUBSCRIPTION FOR 14 DAYS!

DBV Technologies S.A. Stock News NASDAQ:DBVT

Allergy Immunotherapies Market study by The Insight Partners provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. This Read more
Montrouge, France, June 2, 2021 DBV Technologies to Present at Upcoming Investor Conferences DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biop Read more

DBV Technologies to Present at Upcoming Investor Conferences

05:30am, Wednesday, 02'nd Jun 2021 GlobeNewswire
Montrouge, France, June 2, 2021 Read more

Dbv Technologies Ads (DBVT) falls 7.5% for May 19

10:00pm, Wednesday, 19'th May 2021 Equities
Dbv Technologies Ads (NASDAQ: DBVT) shares fell -7.50% to end trading Wednesday at $6.04 per share - a net change of $-0.49. Shares traded between $6.14 and $5.97 throughout the day. 104066 shares of Dbv Technologies Ads exchanged hands. Visit Dbv Technologies Adss profile for more information. About The Nasdaq Stock Market The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world\''s leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook. To get more information on Dbv Technologies Ads and to follow the companys latest updates, you can visit the companys profile page here: Dbv Technologies Adss Profile . For more news on the financial markets be sure to visit Equities News . Also, dont forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week. Sources: Chart is provided by TradingView based on 15-minute-delayed prices. Read more
Montrouge, France, May 19, 2021 DBV Technologies Announces Results of its 2021 Ordinary and Extraordinary General Meeting and the Appointment of Dr. Adora Ndu, Pharm.D., J.D., and Dr. Ravi Madduri Read more
Montrouge, France, May 19, 2021 DBV Technologies Announces Results of its 2021 Ordinary and Extraordinary General Meeting andthe Appointment of Dr. Adora Ndu, Pharm.D., J.D., and Dr. Ravi Madduri Rao, M.D., Ph.D. Read more
DBV Technologies Announces Results of its 2021 Ordinary and Extraordinary General Meeting andthe Appointment of Dr. Adora Ndu, Pharm.D., J.D., and Dr. Ravi Madduri Rao, M.D., Ph.D., as Members of its Board of Directors Read more
Monthly information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2021 (Article 223-16 of the General Regulations of the Autorité des Marchés Read more
DBV Technologies S.A. (NASDAQ:DBVT) has been assigned an average rating of Hold from the eleven ratings firms that are currently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month [] Read more
DUBLIN--(BUSINESS WIRE)--The "Allergy Immunotherapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global allergy immunotherapies market reached a value of US$ 2.3 Billion in 2020. Looking forward, the publisher expects the global allergy immunotherapies market to reach a value of US$ 4.10 Billion by 2026, exhibiting a CAGR of 10.50% during 2021-2026. Allergy immunotherapy, also known as Read more
Montrouge, France, March 5, 2021 DBV Technologies to Participate in the H.C. Wainwright Global Life Sciences Conference DBV Technologies (GREY:DBVTF), a clinical-stage biopharmaceutical company, today announced that Daniel Tassé, Chief Executive Officer, will present at the H.C. Wainwright Global Life Sciences Conference being held March 9-10, 2021. A webcast of the presentation at the H.C.… Read More »DBV Technologies to Participate in the H.C. Wainwright Global Life Sciences Conference Read more

28 Stocks Moving in Friday's Pre-Market Session

12:00pm, Friday, 15'th Jan 2021 Benzinga
Gainers Atlantic Power Corporation (NYSE: AT ) shares rose 40.5% to $2.95 in pre-market trading as the company agreed to be acquired by I Squared Capital, a leading global infrastructure investor. DBV Technologies S.A. (NASDAQ: DBVT ) shares rose 34.5% to $5.03 in pre-market trading after the company issued an update on investigational viaskin peanut for children ages 4-11 years. ObsEva SA (NASDAQ: OBSV ) shares rose 22.2% to $3.08 in pre-market trading after jumping over 19% on Thursday. ObsEva recently provided updates on Yselty clinical development program. BlackBerry Limited (NYSE: BB ) rose 19% to $10.83 in pre-market trading after the company sold 90 patents linked to smartphone technology to China’s Huawei, according to the U.S. Patent and Trademark Office records cited by Canada’s The Globe and Mail newspaper. Tufin Software Technologies Ltd. (NYSE: TUFN ) rose 17.2% to $18.02 in pre-market trading after the company raised preliminary Q4 sales guidance. The company also named Raymond Brancato as Chief Revenue Officer. Read more
DBV Technologies’ goal of delivering an anti-allergy skin patch has proven a tough nut to crack. After the FDA turned its patch away last year—saying its designs would need to be modified and retested—it's now planning to lay off two-thirds of its staff. Read more
Montrouge, France, January 7, 2021 DBV Technologies Announces Change in U.S. Reporting Status and Final Approval of Global Restructuring Process DBV Technologies S.A. (GREY:DBVTF), a clinical-stage biopharmaceutical company, today announced that it has determined that it now qualifies as a U.S. domestic issuer rather than a foreign private issuer in the United States. As of… Read More »DBV Technologies Announces Change in U.S. Reporting Status and Final Approval of Global Restructuring Process Read more

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE